Skip to main content

Table 1 Baseline characteristics of 123 CHB patients treated with bicyclol tablets

From: Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

Variables

All patients (n = 123)

Normal ALT (n = 38)

Elevated ALT (n = 85)

Demographic characteristics

 Median age, years (range)

35 (18–65)

39 (23–61)

33 (18–65)

 Males, n (%)

85 (69.1)

25 (65.8)

60 (70.6)

Laboratory data

 Median ALT, U/L (range)

68.0 (5–483)

24.5 (5–50)

98 (51–483)

 Median AST, U/L (range)

44.0 (15–323)

23.0 (15–40)

56 (27–323)

 HBeAg (+), n (%)

66 (53.7)

9 (23.7)

57 (67.1)

 HBV DNA (mean ± SD), log10IU/ml

5.99 ± 1.76

4.43 ± 1.79

6.67 ± 1.24

Liver histology

 Inflammation activity, n (%)

  G2, n (%)

61 (87.1)

20 (80.0)

41 (91.1)

  G3, n (%)

9 (12.9)

5 (20.0)

4 (8.9)

 Fibrosis (%)

  S1, n (%)

22 (31.4)

7 (28.0)

15 (33.3)

  S2, n (%)

37 (52.8)

11 (44.0)

26 (57.8)

  S3, n (%)

11 (15.8)

7 (28.0)

4 (8.9)